Illumina Body Map 2: averaged replicates
Gene Symbol | Gene ID | Gene Info |
---|---|---|
SPI1
|
ENSG00000066336.7 | Spi-1 proto-oncogene |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
SPI1 | hg19_v2_chr11_-_47400062_47400077 | 0.84 | 1.3e-09 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr1_+_198607801 | 33.49 |
ENST00000367379.1
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C |
chr1_+_198608146 | 29.37 |
ENST00000367376.2
ENST00000352140.3 ENST00000594404.1 ENST00000598951.1 ENST00000530727.1 ENST00000442510.2 ENST00000367367.4 ENST00000348564.6 ENST00000367364.1 ENST00000413409.2 |
PTPRC
|
protein tyrosine phosphatase, receptor type, C |
chr1_-_167487808 | 27.34 |
ENST00000392122.3
|
CD247
|
CD247 molecule |
chr1_+_198608292 | 27.25 |
ENST00000418674.1
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C |
chr1_-_167487758 | 27.01 |
ENST00000362089.5
|
CD247
|
CD247 molecule |
chr1_-_207095212 | 23.24 |
ENST00000420007.2
|
FAIM3
|
Fas apoptotic inhibitory molecule 3 |
chr11_+_128563652 | 23.16 |
ENST00000527786.2
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor |
chr11_+_60223312 | 23.11 |
ENST00000532491.1
ENST00000532073.1 ENST00000534668.1 ENST00000528313.1 ENST00000533306.1 |
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1 |
chr7_-_45018686 | 22.31 |
ENST00000258787.7
|
MYO1G
|
myosin IG |
chr1_-_207095324 | 21.20 |
ENST00000530505.1
ENST00000367091.3 ENST00000442471.2 |
FAIM3
|
Fas apoptotic inhibitory molecule 3 |
chr11_+_60223225 | 20.72 |
ENST00000524807.1
ENST00000345732.4 |
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1 |
chr9_-_71161505 | 19.17 |
ENST00000446290.1
|
RP11-274B18.2
|
RP11-274B18.2 |
chr16_-_30393752 | 18.69 |
ENST00000566517.1
ENST00000605106.1 |
SEPT1
SEPT1
|
septin 1 Uncharacterized protein |
chr2_+_233924548 | 18.66 |
ENST00000422935.1
|
INPP5D
|
inositol polyphosphate-5-phosphatase, 145kDa |
chr19_+_42381173 | 18.26 |
ENST00000221972.3
|
CD79A
|
CD79a molecule, immunoglobulin-associated alpha |
chr6_-_32160622 | 18.12 |
ENST00000487761.1
ENST00000375040.3 |
GPSM3
|
G-protein signaling modulator 3 |
chr5_+_57787254 | 17.84 |
ENST00000502276.1
ENST00000396776.2 ENST00000511930.1 |
GAPT
|
GRB2-binding adaptor protein, transmembrane |
chr5_-_66492562 | 15.91 |
ENST00000256447.4
|
CD180
|
CD180 molecule |
chr22_+_37678424 | 15.88 |
ENST00000248901.6
|
CYTH4
|
cytohesin 4 |
chr6_+_144980954 | 15.53 |
ENST00000367525.3
|
UTRN
|
utrophin |
chr6_+_31553901 | 15.36 |
ENST00000418507.2
ENST00000438075.2 ENST00000376100.3 ENST00000376111.4 |
LST1
|
leukocyte specific transcript 1 |
chr2_+_69002052 | 15.31 |
ENST00000497079.1
|
ARHGAP25
|
Rho GTPase activating protein 25 |
chr2_+_69001913 | 15.14 |
ENST00000409030.3
ENST00000409220.1 |
ARHGAP25
|
Rho GTPase activating protein 25 |
chr19_-_8642289 | 14.99 |
ENST00000596675.1
ENST00000338257.8 |
MYO1F
|
myosin IF |
chr6_+_31553978 | 14.99 |
ENST00000376096.1
ENST00000376099.1 ENST00000376110.3 |
LST1
|
leukocyte specific transcript 1 |
chr22_+_37678505 | 14.93 |
ENST00000402997.1
ENST00000405206.3 |
CYTH4
|
cytohesin 4 |
chr5_-_169725231 | 14.88 |
ENST00000046794.5
|
LCP2
|
lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) |
chr1_-_150738261 | 14.71 |
ENST00000448301.2
ENST00000368985.3 |
CTSS
|
cathepsin S |
chr1_-_183560011 | 14.59 |
ENST00000367536.1
|
NCF2
|
neutrophil cytosolic factor 2 |
chr10_-_72362515 | 14.58 |
ENST00000373209.2
ENST00000441259.1 |
PRF1
|
perforin 1 (pore forming protein) |
chr16_+_30484021 | 14.56 |
ENST00000358164.5
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
chr15_+_81589254 | 14.56 |
ENST00000394652.2
|
IL16
|
interleukin 16 |
chr12_+_54891495 | 14.46 |
ENST00000293373.6
|
NCKAP1L
|
NCK-associated protein 1-like |
chr2_+_233925064 | 14.37 |
ENST00000359570.5
ENST00000538935.1 |
INPP5D
|
inositol polyphosphate-5-phosphatase, 145kDa |
chr1_-_207096529 | 14.31 |
ENST00000525793.1
ENST00000529560.1 |
FAIM3
|
Fas apoptotic inhibitory molecule 3 |
chr2_+_233925038 | 14.14 |
ENST00000451407.1
|
INPP5D
|
inositol polyphosphate-5-phosphatase, 145kDa |
chr16_+_30483962 | 14.12 |
ENST00000356798.6
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
chr6_+_31543334 | 14.08 |
ENST00000449264.2
|
TNF
|
tumor necrosis factor |
chr11_-_118083600 | 13.98 |
ENST00000524477.1
|
AMICA1
|
adhesion molecule, interacts with CXADR antigen 1 |
chr1_-_161039456 | 13.95 |
ENST00000368016.3
|
ARHGAP30
|
Rho GTPase activating protein 30 |
chr2_+_204801471 | 13.67 |
ENST00000316386.6
ENST00000435193.1 |
ICOS
|
inducible T-cell co-stimulator |
chr16_+_30484054 | 13.66 |
ENST00000564118.1
ENST00000454514.2 ENST00000433423.2 |
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
chr14_-_23284703 | 13.62 |
ENST00000555911.1
|
SLC7A7
|
solute carrier family 7 (amino acid transporter light chain, y+L system), member 7 |
chr13_-_46756351 | 13.48 |
ENST00000323076.2
|
LCP1
|
lymphocyte cytosolic protein 1 (L-plastin) |
chr9_-_137809718 | 13.40 |
ENST00000371806.3
|
FCN1
|
ficolin (collagen/fibrinogen domain containing) 1 |
chr17_-_47287928 | 13.37 |
ENST00000507680.1
|
GNGT2
|
guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2 |
chr16_-_30394143 | 13.33 |
ENST00000321367.3
ENST00000571393.1 |
SEPT1
|
septin 1 |
chr7_-_115670792 | 13.13 |
ENST00000265440.7
ENST00000393485.1 |
TFEC
|
transcription factor EC |
chrX_+_128913906 | 13.07 |
ENST00000356892.3
|
SASH3
|
SAM and SH3 domain containing 3 |
chr9_+_95726243 | 13.04 |
ENST00000416701.2
|
FGD3
|
FYVE, RhoGEF and PH domain containing 3 |
chr11_-_3862059 | 13.01 |
ENST00000396978.1
|
RHOG
|
ras homolog family member G |
chr4_-_153601136 | 12.92 |
ENST00000504064.1
ENST00000304385.3 |
TMEM154
|
transmembrane protein 154 |
chr11_+_118175596 | 12.87 |
ENST00000528600.1
|
CD3E
|
CD3e molecule, epsilon (CD3-TCR complex) |
chrX_-_47489244 | 12.78 |
ENST00000469388.1
ENST00000396992.3 ENST00000377005.2 |
CFP
|
complement factor properdin |
chr5_+_35856951 | 12.64 |
ENST00000303115.3
ENST00000343305.4 ENST00000506850.1 ENST00000511982.1 |
IL7R
|
interleukin 7 receptor |
chr19_+_42381337 | 12.51 |
ENST00000597454.1
ENST00000444740.2 |
CD79A
|
CD79a molecule, immunoglobulin-associated alpha |
chr11_-_47400062 | 12.48 |
ENST00000533030.1
|
SPI1
|
spleen focus forming virus (SFFV) proviral integration oncogene |
chr16_-_29757272 | 12.42 |
ENST00000329410.3
|
C16orf54
|
chromosome 16 open reading frame 54 |
chr17_+_43299156 | 12.25 |
ENST00000331495.3
|
FMNL1
|
formin-like 1 |
chr17_+_47287749 | 12.04 |
ENST00000419580.2
|
ABI3
|
ABI family, member 3 |
chr7_-_115670804 | 11.91 |
ENST00000320239.7
|
TFEC
|
transcription factor EC |
chr1_-_183559693 | 11.91 |
ENST00000367535.3
ENST00000413720.1 ENST00000418089.1 |
NCF2
|
neutrophil cytosolic factor 2 |
chr19_-_6481776 | 11.86 |
ENST00000543576.1
ENST00000590173.1 ENST00000381480.2 |
DENND1C
|
DENN/MADD domain containing 1C |
chr11_+_118175132 | 11.80 |
ENST00000361763.4
|
CD3E
|
CD3e molecule, epsilon (CD3-TCR complex) |
chr19_-_6481759 | 11.80 |
ENST00000588421.1
|
DENND1C
|
DENN/MADD domain containing 1C |
chr11_+_67171548 | 11.77 |
ENST00000542590.1
|
TBC1D10C
|
TBC1 domain family, member 10C |
chr11_+_67171391 | 11.76 |
ENST00000312390.5
|
TBC1D10C
|
TBC1 domain family, member 10C |
chr11_-_47399942 | 11.61 |
ENST00000227163.4
|
SPI1
|
spleen focus forming virus (SFFV) proviral integration oncogene |
chr11_+_67171358 | 11.56 |
ENST00000526387.1
|
TBC1D10C
|
TBC1 domain family, member 10C |
chr1_-_25256368 | 11.54 |
ENST00000308873.6
|
RUNX3
|
runt-related transcription factor 3 |
chr17_+_43299241 | 11.49 |
ENST00000328118.3
|
FMNL1
|
formin-like 1 |
chr16_-_21663919 | 11.31 |
ENST00000569602.1
|
IGSF6
|
immunoglobulin superfamily, member 6 |
chr11_+_128563948 | 11.21 |
ENST00000534087.2
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor |
chr6_-_159466136 | 11.11 |
ENST00000367066.3
ENST00000326965.6 |
TAGAP
|
T-cell activation RhoGTPase activating protein |
chr4_+_100737954 | 11.07 |
ENST00000296414.7
ENST00000512369.1 |
DAPP1
|
dual adaptor of phosphotyrosine and 3-phosphoinositides |
chr4_+_68424434 | 10.82 |
ENST00000265404.2
ENST00000396225.1 |
STAP1
|
signal transducing adaptor family member 1 |
chr11_-_47400078 | 10.81 |
ENST00000378538.3
|
SPI1
|
spleen focus forming virus (SFFV) proviral integration oncogene |
chr15_-_40600111 | 10.81 |
ENST00000543785.2
ENST00000260402.3 |
PLCB2
|
phospholipase C, beta 2 |
chr2_-_235405168 | 10.79 |
ENST00000339728.3
|
ARL4C
|
ADP-ribosylation factor-like 4C |
chr16_+_28996114 | 10.78 |
ENST00000395461.3
|
LAT
|
linker for activation of T cells |
chr12_+_7055767 | 10.70 |
ENST00000447931.2
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6 |
chrX_+_135730297 | 10.69 |
ENST00000370629.2
|
CD40LG
|
CD40 ligand |
chr16_-_21663950 | 10.67 |
ENST00000268389.4
|
IGSF6
|
immunoglobulin superfamily, member 6 |
chr16_+_29674277 | 10.65 |
ENST00000395389.2
|
SPN
|
sialophorin |
chr11_-_47400032 | 10.63 |
ENST00000533968.1
|
SPI1
|
spleen focus forming virus (SFFV) proviral integration oncogene |
chr1_+_32716857 | 10.63 |
ENST00000482949.1
ENST00000495610.2 |
LCK
|
lymphocyte-specific protein tyrosine kinase |
chr1_+_32716840 | 10.52 |
ENST00000336890.5
|
LCK
|
lymphocyte-specific protein tyrosine kinase |
chr7_+_50344289 | 10.51 |
ENST00000413698.1
ENST00000359197.5 ENST00000331340.3 ENST00000357364.4 ENST00000343574.5 ENST00000349824.4 ENST00000346667.4 ENST00000440768.2 |
IKZF1
|
IKAROS family zinc finger 1 (Ikaros) |
chr8_-_133772794 | 10.49 |
ENST00000519187.1
ENST00000523829.1 ENST00000356838.3 ENST00000377901.4 ENST00000519304.1 |
TMEM71
|
transmembrane protein 71 |
chr12_-_9760482 | 10.33 |
ENST00000229402.3
|
KLRB1
|
killer cell lectin-like receptor subfamily B, member 1 |
chr15_+_77287426 | 10.31 |
ENST00000558012.1
ENST00000267939.5 ENST00000379595.3 |
PSTPIP1
|
proline-serine-threonine phosphatase interacting protein 1 |
chr17_+_4618734 | 10.30 |
ENST00000571206.1
|
ARRB2
|
arrestin, beta 2 |
chr22_-_37545972 | 10.30 |
ENST00000216223.5
|
IL2RB
|
interleukin 2 receptor, beta |
chr7_-_3083573 | 10.27 |
ENST00000396946.4
|
CARD11
|
caspase recruitment domain family, member 11 |
chr1_+_32739733 | 10.26 |
ENST00000333070.4
|
LCK
|
lymphocyte-specific protein tyrosine kinase |
chr12_-_53601055 | 10.25 |
ENST00000552972.1
ENST00000422257.3 ENST00000267082.5 |
ITGB7
|
integrin, beta 7 |
chr6_-_6320875 | 10.24 |
ENST00000451619.1
|
F13A1
|
coagulation factor XIII, A1 polypeptide |
chr11_+_60869867 | 10.23 |
ENST00000347785.3
|
CD5
|
CD5 molecule |
chr2_+_182321925 | 10.17 |
ENST00000339307.4
ENST00000397033.2 |
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor) |
chr1_+_32739714 | 10.13 |
ENST00000461712.2
ENST00000373562.3 ENST00000477031.2 ENST00000373557.2 |
LCK
|
lymphocyte-specific protein tyrosine kinase |
chr17_-_37934466 | 10.10 |
ENST00000583368.1
|
IKZF3
|
IKAROS family zinc finger 3 (Aiolos) |
chr22_+_44577237 | 10.06 |
ENST00000415224.1
ENST00000417767.1 |
PARVG
|
parvin, gamma |
chr1_+_111415757 | 10.05 |
ENST00000429072.2
ENST00000271324.5 |
CD53
|
CD53 molecule |
chr14_-_23284675 | 10.04 |
ENST00000555959.1
|
SLC7A7
|
solute carrier family 7 (amino acid transporter light chain, y+L system), member 7 |
chr5_+_169064245 | 10.00 |
ENST00000256935.8
|
DOCK2
|
dedicator of cytokinesis 2 |
chr14_+_22554680 | 9.99 |
ENST00000390451.2
|
TRAV23DV6
|
T cell receptor alpha variable 23/delta variable 6 |
chr1_-_157522180 | 9.98 |
ENST00000356953.4
ENST00000368188.2 ENST00000368190.3 ENST00000368189.3 |
FCRL5
|
Fc receptor-like 5 |
chr16_+_28996364 | 9.96 |
ENST00000564277.1
|
LAT
|
linker for activation of T cells |
chr16_+_28996572 | 9.93 |
ENST00000360872.5
ENST00000566177.1 ENST00000354453.4 |
LAT
|
linker for activation of T cells |
chr12_-_53601000 | 9.92 |
ENST00000338737.4
ENST00000549086.2 |
ITGB7
|
integrin, beta 7 |
chr9_-_117150243 | 9.91 |
ENST00000374088.3
|
AKNA
|
AT-hook transcription factor |
chr11_+_60869980 | 9.88 |
ENST00000544014.1
|
CD5
|
CD5 molecule |
chr14_-_23285011 | 9.87 |
ENST00000397532.3
|
SLC7A7
|
solute carrier family 7 (amino acid transporter light chain, y+L system), member 7 |
chr6_-_159466042 | 9.87 |
ENST00000338313.5
|
TAGAP
|
T-cell activation RhoGTPase activating protein |
chrX_+_78200913 | 9.84 |
ENST00000171757.2
|
P2RY10
|
purinergic receptor P2Y, G-protein coupled, 10 |
chr14_-_23285069 | 9.84 |
ENST00000554758.1
ENST00000397528.4 |
SLC7A7
|
solute carrier family 7 (amino acid transporter light chain, y+L system), member 7 |
chr16_+_28996416 | 9.79 |
ENST00000395456.2
ENST00000454369.2 |
LAT
|
linker for activation of T cells |
chr4_-_109089573 | 9.76 |
ENST00000265165.1
|
LEF1
|
lymphoid enhancer-binding factor 1 |
chr11_+_60739115 | 9.74 |
ENST00000344028.5
ENST00000346437.4 |
CD6
|
CD6 molecule |
chr8_-_133772870 | 9.74 |
ENST00000522334.1
ENST00000519016.1 |
TMEM71
|
transmembrane protein 71 |
chr10_-_6104253 | 9.72 |
ENST00000256876.6
ENST00000379954.1 ENST00000379959.3 |
IL2RA
|
interleukin 2 receptor, alpha |
chrX_+_78200829 | 9.72 |
ENST00000544091.1
|
P2RY10
|
purinergic receptor P2Y, G-protein coupled, 10 |
chr9_+_273038 | 9.68 |
ENST00000487230.1
ENST00000469391.1 |
DOCK8
|
dedicator of cytokinesis 8 |
chr1_-_161039753 | 9.67 |
ENST00000368015.1
|
ARHGAP30
|
Rho GTPase activating protein 30 |
chr11_+_60739249 | 9.60 |
ENST00000542157.1
ENST00000433107.2 ENST00000452451.2 ENST00000352009.5 |
CD6
|
CD6 molecule |
chr22_-_30662828 | 9.59 |
ENST00000403463.1
ENST00000215781.2 |
OSM
|
oncostatin M |
chr6_+_31554612 | 9.50 |
ENST00000211921.7
|
LST1
|
leukocyte specific transcript 1 |
chr19_+_49838653 | 9.50 |
ENST00000598095.1
ENST00000426897.2 ENST00000323906.4 ENST00000535669.2 ENST00000597602.1 ENST00000595660.1 |
CD37
|
CD37 molecule |
chr12_+_7055631 | 9.49 |
ENST00000543115.1
ENST00000399448.1 |
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6 |
chr1_+_161676739 | 9.49 |
ENST00000236938.6
ENST00000367959.2 ENST00000546024.1 ENST00000540521.1 ENST00000367949.2 ENST00000350710.3 ENST00000540926.1 |
FCRLA
|
Fc receptor-like A |
chr17_-_72527605 | 9.46 |
ENST00000392621.1
ENST00000314401.3 |
CD300LB
|
CD300 molecule-like family member b |
chr11_+_65408273 | 9.46 |
ENST00000394227.3
|
SIPA1
|
signal-induced proliferation-associated 1 |
chrX_+_135730373 | 9.44 |
ENST00000370628.2
|
CD40LG
|
CD40 ligand |
chr1_-_202129704 | 9.41 |
ENST00000476061.1
ENST00000544762.1 ENST00000467283.1 ENST00000464870.1 ENST00000435759.2 ENST00000486116.1 ENST00000543735.1 ENST00000308986.5 ENST00000477625.1 |
PTPN7
|
protein tyrosine phosphatase, non-receptor type 7 |
chr11_+_60739140 | 9.38 |
ENST00000313421.7
|
CD6
|
CD6 molecule |
chr17_+_76126842 | 9.29 |
ENST00000590426.1
ENST00000590799.1 ENST00000318430.5 ENST00000589691.1 |
TMC8
|
transmembrane channel-like 8 |
chr1_-_161039647 | 9.28 |
ENST00000368013.3
|
ARHGAP30
|
Rho GTPase activating protein 30 |
chr17_+_72462525 | 9.26 |
ENST00000360141.3
|
CD300A
|
CD300a molecule |
chrX_-_70331298 | 9.25 |
ENST00000456850.2
ENST00000473378.1 ENST00000487883.1 ENST00000374202.2 |
IL2RG
|
interleukin 2 receptor, gamma |
chr7_-_27135591 | 9.17 |
ENST00000343060.4
ENST00000355633.5 |
HOXA1
|
homeobox A1 |
chr1_-_157522260 | 9.09 |
ENST00000368191.3
ENST00000361835.3 |
FCRL5
|
Fc receptor-like 5 |
chr3_-_183273477 | 9.09 |
ENST00000341319.3
|
KLHL6
|
kelch-like family member 6 |
chr17_-_38721711 | 9.08 |
ENST00000578085.1
ENST00000246657.2 |
CCR7
|
chemokine (C-C motif) receptor 7 |
chr6_+_45390222 | 9.05 |
ENST00000359524.5
|
RUNX2
|
runt-related transcription factor 2 |
chr1_+_153330322 | 9.04 |
ENST00000368738.3
|
S100A9
|
S100 calcium binding protein A9 |
chr15_-_40600026 | 9.03 |
ENST00000456256.2
ENST00000557821.1 |
PLCB2
|
phospholipase C, beta 2 |
chr17_+_7239904 | 8.95 |
ENST00000575425.1
|
ACAP1
|
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 |
chr20_+_24929866 | 8.95 |
ENST00000480798.1
ENST00000376835.2 |
CST7
|
cystatin F (leukocystatin) |
chr1_-_157746909 | 8.89 |
ENST00000392274.3
ENST00000361516.3 ENST00000368181.4 |
FCRL2
|
Fc receptor-like 2 |
chr6_+_31554826 | 8.87 |
ENST00000376089.2
ENST00000396112.2 |
LST1
|
leukocyte specific transcript 1 |
chr4_-_109088940 | 8.84 |
ENST00000438313.2
|
LEF1
|
lymphoid enhancer-binding factor 1 |
chr17_-_72619869 | 8.80 |
ENST00000392619.1
ENST00000426295.2 |
CD300E
|
CD300e molecule |
chr1_+_9711781 | 8.79 |
ENST00000536656.1
ENST00000377346.4 |
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta |
chr6_+_31554456 | 8.77 |
ENST00000339530.4
|
LST1
|
leukocyte specific transcript 1 |
chr15_+_77287715 | 8.73 |
ENST00000559161.1
|
PSTPIP1
|
proline-serine-threonine phosphatase interacting protein 1 |
chr7_+_106505696 | 8.71 |
ENST00000440650.2
ENST00000496166.1 ENST00000473541.1 |
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma |
chr11_+_65407331 | 8.69 |
ENST00000527525.1
|
SIPA1
|
signal-induced proliferation-associated 1 |
chr19_-_36399149 | 8.64 |
ENST00000585901.2
ENST00000544690.2 ENST00000424586.3 ENST00000262629.4 ENST00000589517.1 |
TYROBP
|
TYRO protein tyrosine kinase binding protein |
chr6_+_32811861 | 8.63 |
ENST00000453426.1
|
TAPSAR1
|
TAP1 and PSMB8 antisense RNA 1 |
chr9_+_120466610 | 8.56 |
ENST00000394487.4
|
TLR4
|
toll-like receptor 4 |
chr8_+_56792355 | 8.51 |
ENST00000519728.1
|
LYN
|
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog |
chr12_-_51718436 | 8.45 |
ENST00000544402.1
|
BIN2
|
bridging integrator 2 |
chr10_+_49892904 | 8.44 |
ENST00000360890.2
|
WDFY4
|
WDFY family member 4 |
chr11_-_3862206 | 8.43 |
ENST00000351018.4
|
RHOG
|
ras homolog family member G |
chr20_-_50179368 | 8.40 |
ENST00000609943.1
ENST00000609507.1 |
NFATC2
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 |
chr2_+_68961934 | 8.39 |
ENST00000409202.3
|
ARHGAP25
|
Rho GTPase activating protein 25 |
chr15_-_80263506 | 8.37 |
ENST00000335661.6
|
BCL2A1
|
BCL2-related protein A1 |
chr12_-_57871620 | 8.30 |
ENST00000552604.1
|
ARHGAP9
|
Rho GTPase activating protein 9 |
chr3_-_46249878 | 8.29 |
ENST00000296140.3
|
CCR1
|
chemokine (C-C motif) receptor 1 |
chr12_-_57871567 | 8.25 |
ENST00000551452.1
|
ARHGAP9
|
Rho GTPase activating protein 9 |
chr1_-_168513229 | 8.24 |
ENST00000367819.2
|
XCL2
|
chemokine (C motif) ligand 2 |
chr12_-_15114603 | 8.21 |
ENST00000228945.4
|
ARHGDIB
|
Rho GDP dissociation inhibitor (GDI) beta |
chr17_+_7461613 | 8.21 |
ENST00000438470.1
ENST00000436057.1 |
TNFSF13
|
tumor necrosis factor (ligand) superfamily, member 13 |
chr16_-_89043377 | 8.19 |
ENST00000436887.2
ENST00000448839.1 ENST00000360302.2 |
CBFA2T3
|
core-binding factor, runt domain, alpha subunit 2; translocated to, 3 |
chr1_+_159772121 | 8.18 |
ENST00000339348.5
ENST00000392235.3 ENST00000368106.3 |
FCRL6
|
Fc receptor-like 6 |
chr4_-_164534657 | 8.16 |
ENST00000339875.5
|
MARCH1
|
membrane-associated ring finger (C3HC4) 1, E3 ubiquitin protein ligase |
chr2_-_198175495 | 8.15 |
ENST00000409153.1
ENST00000409919.1 ENST00000539527.1 |
ANKRD44
|
ankyrin repeat domain 44 |
chr14_+_24783906 | 8.13 |
ENST00000396782.2
|
LTB4R
|
leukotriene B4 receptor |
chr8_+_56792377 | 8.09 |
ENST00000520220.2
|
LYN
|
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog |
chrX_-_153192211 | 8.09 |
ENST00000461052.1
ENST00000422091.1 |
ARHGAP4
|
Rho GTPase activating protein 4 |
chr12_-_15114658 | 8.04 |
ENST00000542276.1
|
ARHGDIB
|
Rho GDP dissociation inhibitor (GDI) beta |
chr12_-_57871825 | 8.03 |
ENST00000548139.1
|
ARHGAP9
|
Rho GTPase activating protein 9 |
chr17_+_72462766 | 7.97 |
ENST00000392625.3
ENST00000361933.3 ENST00000310828.5 |
CD300A
|
CD300a molecule |
chr6_+_31554636 | 7.97 |
ENST00000433492.1
|
LST1
|
leukocyte specific transcript 1 |
chr14_-_35344093 | 7.96 |
ENST00000382422.2
|
BAZ1A
|
bromodomain adjacent to zinc finger domain, 1A |
chr1_+_168545711 | 7.93 |
ENST00000367818.3
|
XCL1
|
chemokine (C motif) ligand 1 |
chr2_+_68961905 | 7.93 |
ENST00000295381.3
|
ARHGAP25
|
Rho GTPase activating protein 25 |
chr19_+_36393367 | 7.90 |
ENST00000246551.4
|
HCST
|
hematopoietic cell signal transducer |
chr1_+_161677034 | 7.90 |
ENST00000349527.4
ENST00000309691.6 ENST00000294796.4 ENST00000367953.3 ENST00000367950.1 |
FCRLA
|
Fc receptor-like A |
chr22_+_40322595 | 7.89 |
ENST00000420971.1
ENST00000544756.1 |
GRAP2
|
GRB2-related adaptor protein 2 |
chr22_-_37640277 | 7.83 |
ENST00000401529.3
ENST00000249071.6 |
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
chr1_-_92951607 | 7.76 |
ENST00000427103.1
|
GFI1
|
growth factor independent 1 transcription repressor |
chr9_-_117150303 | 7.76 |
ENST00000312033.3
|
AKNA
|
AT-hook transcription factor |
chr17_+_7461580 | 7.75 |
ENST00000483039.1
ENST00000396542.1 |
TNFSF13
|
tumor necrosis factor (ligand) superfamily, member 13 |
chr2_+_103035102 | 7.73 |
ENST00000264260.2
|
IL18RAP
|
interleukin 18 receptor accessory protein |
chr9_+_120466650 | 7.71 |
ENST00000355622.6
|
TLR4
|
toll-like receptor 4 |
chr11_+_64107663 | 7.70 |
ENST00000356786.5
|
CCDC88B
|
coiled-coil domain containing 88B |
chr1_+_27669719 | 7.68 |
ENST00000473280.1
|
SYTL1
|
synaptotagmin-like 1 |
chr2_-_175499294 | 7.64 |
ENST00000392547.2
|
WIPF1
|
WAS/WASL interacting protein family, member 1 |
chrX_-_153979315 | 7.64 |
ENST00000369575.3
ENST00000369568.4 ENST00000424127.2 |
GAB3
|
GRB2-associated binding protein 3 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
18.0 | 90.1 | GO:2000471 | regulation of hematopoietic stem cell migration(GO:2000471) positive regulation of hematopoietic stem cell migration(GO:2000473) |
10.8 | 10.8 | GO:1903970 | negative regulation of macrophage colony-stimulating factor signaling pathway(GO:1902227) negative regulation of response to macrophage colony-stimulating factor(GO:1903970) negative regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903973) |
9.4 | 47.2 | GO:0045659 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
9.1 | 45.5 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
8.6 | 17.2 | GO:1902567 | negative regulation of eosinophil activation(GO:1902567) |
7.1 | 50.0 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
6.9 | 6.9 | GO:0034125 | negative regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034125) |
6.5 | 19.6 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
6.1 | 30.3 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
5.5 | 16.6 | GO:0070668 | regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
4.9 | 24.7 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
4.7 | 14.1 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) positive regulation of translational initiation by iron(GO:0045994) positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
4.5 | 18.2 | GO:0001808 | negative regulation of type IV hypersensitivity(GO:0001808) |
4.5 | 13.5 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
4.5 | 22.3 | GO:1904844 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
4.3 | 43.4 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
4.0 | 28.1 | GO:0071461 | cellular response to redox state(GO:0071461) |
3.9 | 27.3 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
3.8 | 11.4 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
3.7 | 11.0 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
3.7 | 29.3 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
3.6 | 18.2 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
3.6 | 36.3 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
3.6 | 14.5 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
3.3 | 10.0 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
3.3 | 6.6 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
3.2 | 9.7 | GO:0061485 | memory T cell proliferation(GO:0061485) |
3.0 | 9.0 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
2.9 | 20.4 | GO:2000538 | regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
2.8 | 19.8 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
2.7 | 18.6 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
2.7 | 15.9 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
2.6 | 49.9 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
2.6 | 7.8 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
2.5 | 17.3 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
2.4 | 18.9 | GO:0033029 | regulation of neutrophil apoptotic process(GO:0033029) |
2.4 | 2.4 | GO:0014839 | myoblast migration involved in skeletal muscle regeneration(GO:0014839) |
2.3 | 9.4 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
2.3 | 43.4 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
2.3 | 49.7 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
2.2 | 6.7 | GO:0045083 | negative regulation of interleukin-12 biosynthetic process(GO:0045083) |
2.2 | 32.4 | GO:0048290 | isotype switching to IgA isotypes(GO:0048290) |
2.1 | 12.6 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
2.1 | 10.3 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
1.9 | 7.6 | GO:0051225 | spindle assembly(GO:0051225) |
1.9 | 1.9 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
1.9 | 5.6 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
1.8 | 7.3 | GO:0061358 | negative regulation of Wnt protein secretion(GO:0061358) |
1.8 | 10.7 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
1.8 | 7.1 | GO:1903445 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
1.7 | 7.0 | GO:0046671 | negative regulation of cellular pH reduction(GO:0032848) CD8-positive, alpha-beta T cell lineage commitment(GO:0043375) negative regulation of retinal cell programmed cell death(GO:0046671) |
1.7 | 5.1 | GO:0002352 | B cell negative selection(GO:0002352) post-embryonic camera-type eye morphogenesis(GO:0048597) |
1.7 | 59.3 | GO:0045730 | respiratory burst(GO:0045730) |
1.7 | 13.5 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
1.7 | 6.8 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
1.6 | 6.6 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
1.6 | 9.7 | GO:0032625 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
1.6 | 11.1 | GO:0003172 | primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) |
1.5 | 4.5 | GO:2000588 | positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
1.5 | 44.9 | GO:0035855 | megakaryocyte development(GO:0035855) |
1.5 | 20.7 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
1.5 | 4.4 | GO:0001810 | regulation of type I hypersensitivity(GO:0001810) positive regulation of type I hypersensitivity(GO:0001812) type I hypersensitivity(GO:0016068) |
1.4 | 7.0 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
1.4 | 1.4 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
1.3 | 141.3 | GO:0042100 | B cell proliferation(GO:0042100) |
1.3 | 29.0 | GO:0002418 | immune response to tumor cell(GO:0002418) |
1.3 | 6.5 | GO:0038155 | interleukin-23-mediated signaling pathway(GO:0038155) |
1.3 | 54.4 | GO:0070207 | protein homotrimerization(GO:0070207) |
1.3 | 3.8 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
1.2 | 2.4 | GO:0003274 | endocardial cushion fusion(GO:0003274) |
1.2 | 37.5 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
1.2 | 9.6 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
1.2 | 2.4 | GO:0036166 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
1.1 | 6.7 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
1.1 | 6.6 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
1.1 | 5.4 | GO:0052056 | modulation by virus of host molecular function(GO:0039506) suppression by virus of host molecular function(GO:0039507) suppression by virus of host catalytic activity(GO:0039513) modulation by virus of host catalytic activity(GO:0039516) suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process(GO:0039650) negative regulation by symbiont of host catalytic activity(GO:0052053) negative regulation by symbiont of host molecular function(GO:0052056) modulation by symbiont of host catalytic activity(GO:0052148) |
1.1 | 3.2 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
1.1 | 13.7 | GO:0002517 | T cell tolerance induction(GO:0002517) |
1.0 | 4.2 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
1.0 | 5.1 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
1.0 | 2.1 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
1.0 | 3.0 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
1.0 | 9.1 | GO:0002467 | germinal center formation(GO:0002467) |
1.0 | 9.0 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
1.0 | 5.0 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
1.0 | 23.7 | GO:0051014 | actin filament severing(GO:0051014) |
1.0 | 2.9 | GO:1990637 | response to prolactin(GO:1990637) |
1.0 | 2.9 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
1.0 | 4.8 | GO:0002349 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
1.0 | 3.8 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
0.9 | 13.3 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.9 | 3.7 | GO:0002384 | hepatic immune response(GO:0002384) |
0.9 | 12.8 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.9 | 3.7 | GO:0061056 | sclerotome development(GO:0061056) |
0.9 | 4.5 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.9 | 0.9 | GO:0003249 | cell proliferation involved in heart valve morphogenesis(GO:0003249) regulation of cell proliferation involved in heart valve morphogenesis(GO:0003250) |
0.9 | 15.1 | GO:0030220 | platelet formation(GO:0030220) |
0.9 | 7.9 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.9 | 4.3 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.9 | 5.2 | GO:0071315 | cellular response to morphine(GO:0071315) cellular response to isoquinoline alkaloid(GO:0071317) |
0.9 | 2.6 | GO:0060119 | auditory receptor cell development(GO:0060117) inner ear receptor cell development(GO:0060119) |
0.9 | 12.1 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.9 | 8.6 | GO:0070424 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) |
0.9 | 4.3 | GO:0002347 | response to tumor cell(GO:0002347) |
0.9 | 4.3 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.8 | 1.7 | GO:0072738 | response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
0.8 | 3.3 | GO:0001928 | regulation of exocyst assembly(GO:0001928) regulation of exocyst localization(GO:0060178) |
0.8 | 10.0 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.8 | 3.3 | GO:0097045 | phosphatidylserine exposure on blood platelet(GO:0097045) |
0.8 | 12.4 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.8 | 4.9 | GO:2000503 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.8 | 4.8 | GO:0002507 | tolerance induction(GO:0002507) |
0.8 | 19.6 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.8 | 1.6 | GO:0045168 | cell-cell signaling involved in cell fate commitment(GO:0045168) negative regulation of auditory receptor cell differentiation(GO:0045608) |
0.8 | 17.9 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.8 | 7.7 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.8 | 10.0 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.8 | 43.0 | GO:0002279 | mast cell activation involved in immune response(GO:0002279) mast cell degranulation(GO:0043303) |
0.8 | 1.5 | GO:0007518 | myoblast fate determination(GO:0007518) |
0.8 | 1.5 | GO:0045360 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
0.7 | 9.0 | GO:1902563 | regulation of neutrophil activation(GO:1902563) |
0.7 | 55.3 | GO:0032945 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) |
0.7 | 2.2 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.7 | 11.5 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.7 | 7.1 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.7 | 3.5 | GO:0015783 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
0.7 | 9.0 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.7 | 7.6 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.7 | 13.1 | GO:0014877 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.7 | 4.1 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.7 | 14.3 | GO:0045576 | mast cell activation(GO:0045576) |
0.7 | 6.1 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.7 | 4.7 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.7 | 20.7 | GO:0010447 | response to acidic pH(GO:0010447) |
0.7 | 2.7 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.7 | 7.3 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.7 | 3.9 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.7 | 4.6 | GO:0006226 | dUMP biosynthetic process(GO:0006226) |
0.6 | 1.9 | GO:1903676 | regulation of cap-dependent translational initiation(GO:1903674) positive regulation of cap-dependent translational initiation(GO:1903676) |
0.6 | 1.9 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.6 | 8.3 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.6 | 4.4 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.6 | 3.7 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.6 | 23.8 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.6 | 14.6 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.6 | 3.0 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.6 | 10.7 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.6 | 7.0 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.6 | 6.8 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.6 | 3.9 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.6 | 5.0 | GO:0097324 | melanocyte migration(GO:0097324) positive regulation of lens fiber cell differentiation(GO:1902748) |
0.6 | 3.3 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
0.5 | 13.1 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.5 | 4.3 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.5 | 0.5 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
0.5 | 11.2 | GO:0090520 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
0.5 | 37.1 | GO:0072676 | lymphocyte migration(GO:0072676) |
0.5 | 10.0 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.5 | 2.1 | GO:1905203 | regulation of connective tissue replacement(GO:1905203) positive regulation of connective tissue replacement(GO:1905205) |
0.5 | 22.5 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
0.5 | 3.1 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.5 | 6.5 | GO:0045954 | positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.5 | 7.0 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.5 | 2.5 | GO:2000568 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
0.5 | 11.5 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.5 | 7.6 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.5 | 3.8 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.5 | 1.9 | GO:0032416 | negative regulation of sodium:proton antiporter activity(GO:0032416) |
0.5 | 3.8 | GO:0007296 | vitellogenesis(GO:0007296) |
0.5 | 3.3 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.5 | 5.1 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) |
0.5 | 2.7 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.4 | 14.3 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.4 | 38.0 | GO:0031295 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.4 | 0.9 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.4 | 3.8 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.4 | 7.6 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.4 | 4.2 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.4 | 3.8 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
0.4 | 4.1 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
0.4 | 2.0 | GO:0010157 | response to chlorate(GO:0010157) |
0.4 | 5.3 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.4 | 1.6 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.4 | 4.4 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.4 | 2.8 | GO:1902963 | regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
0.4 | 1.2 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.4 | 6.4 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.4 | 0.8 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.4 | 7.9 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.4 | 0.8 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.4 | 19.2 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.4 | 12.2 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.4 | 6.9 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.4 | 2.3 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.4 | 1.9 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.4 | 15.7 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.4 | 2.2 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.4 | 3.0 | GO:0006116 | NADH oxidation(GO:0006116) |
0.4 | 1.4 | GO:0061743 | motor learning(GO:0061743) |
0.4 | 17.0 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.4 | 1.8 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.3 | 2.8 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.3 | 1.0 | GO:0045575 | histamine biosynthetic process(GO:0001694) basophil activation(GO:0045575) |
0.3 | 1.7 | GO:1904764 | vacuolar transmembrane transport(GO:0034486) chaperone-mediated protein transport involved in chaperone-mediated autophagy(GO:0061741) negative regulation of fibril organization(GO:1902904) chaperone-mediated autophagy translocation complex disassembly(GO:1904764) |
0.3 | 5.1 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.3 | 2.7 | GO:0080009 | mRNA methylation(GO:0080009) |
0.3 | 10.1 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.3 | 2.0 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.3 | 2.7 | GO:0036337 | Fas signaling pathway(GO:0036337) regulation of Fas signaling pathway(GO:1902044) |
0.3 | 3.3 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.3 | 1.3 | GO:0016094 | polyprenol biosynthetic process(GO:0016094) |
0.3 | 1.0 | GO:0060380 | regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) |
0.3 | 2.6 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.3 | 5.2 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.3 | 5.8 | GO:2000587 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.3 | 5.1 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.3 | 4.4 | GO:0007144 | female meiosis I(GO:0007144) |
0.3 | 1.6 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.3 | 2.2 | GO:0043316 | cytotoxic T cell degranulation(GO:0043316) |
0.3 | 8.5 | GO:0097320 | membrane tubulation(GO:0097320) |
0.3 | 8.9 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.3 | 1.5 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
0.3 | 0.9 | GO:0018008 | N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
0.3 | 48.0 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.3 | 7.8 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.3 | 3.9 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.3 | 160.8 | GO:0051056 | regulation of small GTPase mediated signal transduction(GO:0051056) |
0.3 | 2.7 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.3 | 1.7 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
0.3 | 1.5 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.3 | 1.4 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.3 | 0.5 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
0.3 | 1.9 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.3 | 1.9 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
0.3 | 1.9 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.3 | 3.8 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.3 | 0.3 | GO:0015825 | L-serine transport(GO:0015825) |
0.3 | 1.1 | GO:1900154 | regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
0.3 | 2.9 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.3 | 7.7 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.3 | 5.1 | GO:0036065 | fucosylation(GO:0036065) |
0.3 | 2.0 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.3 | 6.5 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.2 | 1.2 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.2 | 2.5 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
0.2 | 0.7 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.2 | 2.1 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
0.2 | 11.1 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.2 | 3.2 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) |
0.2 | 10.3 | GO:0032456 | endocytic recycling(GO:0032456) |
0.2 | 0.9 | GO:0072318 | clathrin coat disassembly(GO:0072318) clathrin-coated pit assembly(GO:1905224) |
0.2 | 3.9 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.2 | 1.4 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
0.2 | 5.4 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.2 | 1.3 | GO:2000234 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
0.2 | 6.9 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.2 | 2.9 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.2 | 2.2 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.2 | 1.5 | GO:0032930 | positive regulation of superoxide anion generation(GO:0032930) |
0.2 | 3.8 | GO:0021794 | thalamus development(GO:0021794) |
0.2 | 1.2 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.2 | 3.0 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.2 | 2.0 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.2 | 0.6 | GO:0048162 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.2 | 2.2 | GO:0060613 | fat pad development(GO:0060613) |
0.2 | 1.2 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.2 | 1.4 | GO:0072719 | cellular response to cisplatin(GO:0072719) |
0.2 | 2.9 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
0.2 | 5.3 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.2 | 2.3 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.2 | 5.9 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.2 | 0.9 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.2 | 6.7 | GO:0006491 | N-glycan processing(GO:0006491) |
0.2 | 2.7 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.2 | 14.8 | GO:0007602 | phototransduction(GO:0007602) |
0.2 | 27.8 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.2 | 3.8 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.2 | 0.9 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
0.2 | 2.4 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.2 | 2.7 | GO:0097178 | ruffle assembly(GO:0097178) |
0.2 | 2.0 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.2 | 1.0 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.2 | 1.2 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.2 | 1.1 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
0.2 | 1.4 | GO:0035897 | proteolysis in other organism(GO:0035897) |
0.2 | 8.9 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
0.2 | 1.9 | GO:0021759 | globus pallidus development(GO:0021759) |
0.2 | 0.3 | GO:0008355 | olfactory learning(GO:0008355) |
0.2 | 26.0 | GO:0002223 | stimulatory C-type lectin receptor signaling pathway(GO:0002223) |
0.2 | 8.2 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.2 | 0.9 | GO:0072752 | cellular response to rapamycin(GO:0072752) |
0.2 | 19.1 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.2 | 0.9 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.2 | 3.4 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
0.2 | 7.1 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.1 | 2.4 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.1 | 2.2 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 1.9 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.1 | 2.7 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 4.1 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 5.6 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.1 | 0.8 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 1.7 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.1 | 2.5 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.1 | 3.4 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.5 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 0.4 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.1 | 1.0 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.1 | 2.6 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.1 | 0.5 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.1 | 0.9 | GO:0007172 | signal complex assembly(GO:0007172) |
0.1 | 2.4 | GO:0006853 | carnitine shuttle(GO:0006853) |
0.1 | 1.6 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.1 | 1.8 | GO:0050880 | regulation of tube size(GO:0035150) regulation of blood vessel size(GO:0050880) |
0.1 | 3.2 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.1 | 2.5 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.1 | 1.0 | GO:0071830 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.1 | 1.1 | GO:0002438 | acute inflammatory response to antigenic stimulus(GO:0002438) |
0.1 | 0.4 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.1 | 14.0 | GO:0006903 | vesicle targeting(GO:0006903) |
0.1 | 2.4 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.1 | 2.9 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.1 | 3.1 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.1 | 7.9 | GO:0048678 | response to axon injury(GO:0048678) |
0.1 | 1.8 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.1 | 0.4 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.1 | 0.2 | GO:1904995 | negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.1 | 1.6 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 0.4 | GO:0098905 | regulation of bundle of His cell action potential(GO:0098905) |
0.1 | 2.3 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.1 | 1.3 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.1 | 5.0 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) |
0.1 | 10.6 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 0.5 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.1 | 1.5 | GO:0034205 | beta-amyloid formation(GO:0034205) |
0.1 | 2.3 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.1 | 2.9 | GO:0030728 | ovulation(GO:0030728) |
0.1 | 0.3 | GO:2001140 | regulation of phospholipid transport(GO:2001138) positive regulation of phospholipid transport(GO:2001140) |
0.1 | 1.2 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.1 | 4.2 | GO:0006298 | mismatch repair(GO:0006298) |
0.1 | 1.5 | GO:0043281 | regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043281) |
0.1 | 3.7 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.1 | 4.5 | GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) |
0.1 | 0.7 | GO:0016556 | mRNA modification(GO:0016556) mRNA pseudouridine synthesis(GO:1990481) |
0.1 | 2.0 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.1 | 7.0 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.1 | 0.4 | GO:0098876 | vesicle-mediated transport to the plasma membrane(GO:0098876) |
0.1 | 1.6 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.1 | 51.2 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
0.1 | 0.6 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 0.9 | GO:0048565 | digestive tract development(GO:0048565) |
0.1 | 1.1 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.1 | 1.5 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
0.1 | 3.0 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.1 | 1.0 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.6 | GO:1902952 | positive regulation of dendritic spine maintenance(GO:1902952) |
0.1 | 4.8 | GO:0030183 | B cell differentiation(GO:0030183) |
0.1 | 3.5 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
0.1 | 0.6 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.1 | 2.1 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.1 | 8.2 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.1 | 1.3 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 1.4 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.1 | 0.9 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.1 | 0.2 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
0.1 | 0.7 | GO:1901339 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.1 | 1.3 | GO:0002003 | angiotensin maturation(GO:0002003) |
0.1 | 1.7 | GO:0060065 | uterus development(GO:0060065) |
0.1 | 0.2 | GO:0003051 | angiotensin-mediated drinking behavior(GO:0003051) sperm ejaculation(GO:0042713) |
0.1 | 2.4 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.1 | 7.3 | GO:0006955 | immune response(GO:0006955) |
0.1 | 12.3 | GO:0002576 | platelet degranulation(GO:0002576) |
0.1 | 0.8 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.1 | 4.6 | GO:0070301 | cellular response to hydrogen peroxide(GO:0070301) |
0.1 | 1.9 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 1.1 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.1 | 0.4 | GO:0052250 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
0.1 | 1.9 | GO:0098751 | bone cell development(GO:0098751) |
0.1 | 1.7 | GO:0048146 | positive regulation of fibroblast proliferation(GO:0048146) |
0.1 | 0.7 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.1 | 1.7 | GO:0015671 | oxygen transport(GO:0015671) |
0.1 | 3.8 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 4.0 | GO:0051881 | regulation of mitochondrial membrane potential(GO:0051881) |
0.1 | 3.9 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.1 | 1.6 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 6.6 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.1 | 1.7 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.1 | 2.2 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.1 | 0.9 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.1 | 2.2 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 3.2 | GO:0042113 | B cell activation(GO:0042113) |
0.1 | 1.3 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
0.1 | 0.2 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
0.1 | 3.0 | GO:0014066 | regulation of phosphatidylinositol 3-kinase signaling(GO:0014066) |
0.1 | 0.6 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 5.2 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.1 | 0.5 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.1 | 3.0 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
0.1 | 2.5 | GO:2000737 | negative regulation of stem cell differentiation(GO:2000737) |
0.1 | 1.6 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.1 | 0.9 | GO:0043586 | tongue development(GO:0043586) |
0.1 | 0.8 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.1 | 0.1 | GO:2000812 | regulation of barbed-end actin filament capping(GO:2000812) |
0.1 | 3.2 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.1 | 0.4 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.1 | 0.5 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.1 | 0.8 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.1 | 1.0 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 1.2 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.0 | 3.2 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.0 | 1.8 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.0 | 1.6 | GO:0015914 | phospholipid transport(GO:0015914) |
0.0 | 5.4 | GO:1990830 | response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
0.0 | 5.5 | GO:2000117 | negative regulation of cysteine-type endopeptidase activity(GO:2000117) |
0.0 | 2.1 | GO:0001824 | blastocyst development(GO:0001824) |
0.0 | 3.3 | GO:0060337 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.0 | 2.8 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 2.0 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.0 | 1.7 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.0 | 1.3 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.0 | 0.6 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.0 | 3.6 | GO:0045727 | positive regulation of translation(GO:0045727) |
0.0 | 6.9 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
0.0 | 0.1 | GO:0033386 | geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
0.0 | 0.6 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.0 | 0.6 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.0 | 0.4 | GO:0035196 | production of miRNAs involved in gene silencing by miRNA(GO:0035196) |
0.0 | 1.1 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.0 | 2.4 | GO:0050709 | negative regulation of protein secretion(GO:0050709) |
0.0 | 4.0 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.0 | 3.2 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 3.7 | GO:0065004 | protein-DNA complex assembly(GO:0065004) |
0.0 | 0.6 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
0.0 | 3.9 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.0 | 0.3 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.0 | 1.2 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.0 | 0.4 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
0.0 | 0.1 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.0 | 2.6 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.0 | 1.7 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 1.7 | GO:0032204 | regulation of telomere maintenance(GO:0032204) |
0.0 | 0.8 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
0.0 | 0.1 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
0.0 | 5.3 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.0 | 0.9 | GO:0021983 | pituitary gland development(GO:0021983) |
0.0 | 0.3 | GO:0031503 | protein complex localization(GO:0031503) cellular protein complex localization(GO:0034629) exocyst localization(GO:0051601) |
0.0 | 0.1 | GO:1904693 | midbrain morphogenesis(GO:1904693) |
0.0 | 0.9 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.0 | 0.9 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.0 | 0.6 | GO:0048015 | phosphatidylinositol-mediated signaling(GO:0048015) inositol lipid-mediated signaling(GO:0048017) |
0.0 | 0.4 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.0 | 0.5 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.0 | 0.7 | GO:0030168 | platelet activation(GO:0030168) |
0.0 | 0.4 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.0 | 8.8 | GO:0002275 | myeloid cell activation involved in immune response(GO:0002275) |
0.0 | 1.3 | GO:0008286 | insulin receptor signaling pathway(GO:0008286) |
0.0 | 0.4 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.0 | 0.3 | GO:0043928 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.0 | 0.3 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 0.3 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.0 | 0.5 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.6 | 99.2 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
6.1 | 30.3 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
4.4 | 30.8 | GO:0019815 | B cell receptor complex(GO:0019815) |
4.3 | 47.6 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
4.1 | 40.7 | GO:0032010 | phagolysosome(GO:0032010) |
4.0 | 15.9 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
3.0 | 14.9 | GO:0036398 | TCR signalosome(GO:0036398) |
2.8 | 16.6 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
2.7 | 8.0 | GO:0008623 | CHRAC(GO:0008623) |
2.5 | 10.1 | GO:0036284 | tubulobulbar complex(GO:0036284) |
2.2 | 20.1 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
2.2 | 6.5 | GO:0042022 | interleukin-12 receptor complex(GO:0042022) |
2.1 | 14.7 | GO:0036021 | endolysosome lumen(GO:0036021) |
2.1 | 14.6 | GO:0044194 | cytolytic granule(GO:0044194) |
2.0 | 46.6 | GO:0042101 | T cell receptor complex(GO:0042101) |
1.9 | 13.4 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
1.8 | 63.5 | GO:0001891 | phagocytic cup(GO:0001891) |
1.8 | 100.6 | GO:0001772 | immunological synapse(GO:0001772) |
1.7 | 43.0 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
1.4 | 22.3 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
1.4 | 4.1 | GO:0002944 | cyclin K-CDK12 complex(GO:0002944) |
1.3 | 18.6 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
1.3 | 8.9 | GO:1902560 | GMP reductase complex(GO:1902560) |
1.3 | 11.3 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
1.2 | 3.7 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
1.2 | 23.7 | GO:0032059 | bleb(GO:0032059) |
1.1 | 20.1 | GO:0031209 | SCAR complex(GO:0031209) |
1.1 | 16.9 | GO:0070938 | contractile ring(GO:0070938) |
1.0 | 1.0 | GO:0071159 | NF-kappaB complex(GO:0071159) |
0.9 | 29.3 | GO:0031527 | filopodium membrane(GO:0031527) |
0.9 | 4.4 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
0.7 | 312.2 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.7 | 2.9 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.7 | 15.0 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.7 | 13.1 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.7 | 2.7 | GO:0045293 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
0.7 | 6.7 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.7 | 6.6 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.6 | 1.9 | GO:0002947 | tumor necrosis factor receptor superfamily complex(GO:0002947) |
0.6 | 2.4 | GO:0048179 | activin receptor complex(GO:0048179) |
0.6 | 5.2 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.5 | 2.7 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.5 | 2.6 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
0.5 | 6.6 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.5 | 2.9 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.5 | 3.7 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.5 | 2.8 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.4 | 0.9 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.4 | 43.1 | GO:0035580 | specific granule lumen(GO:0035580) |
0.4 | 2.6 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.4 | 8.2 | GO:0005916 | fascia adherens(GO:0005916) |
0.4 | 9.6 | GO:0031528 | microvillus membrane(GO:0031528) |
0.4 | 10.6 | GO:0031932 | TORC2 complex(GO:0031932) |
0.4 | 9.4 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.4 | 4.4 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.4 | 1.6 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
0.4 | 2.4 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.4 | 2.3 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.4 | 6.6 | GO:0097433 | dense body(GO:0097433) |
0.4 | 27.9 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.4 | 2.3 | GO:1990037 | Lewy body core(GO:1990037) |
0.4 | 1.5 | GO:0016939 | plus-end kinesin complex(GO:0005873) kinesin II complex(GO:0016939) |
0.4 | 5.1 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.3 | 7.6 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.3 | 33.5 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.3 | 1.9 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.3 | 5.5 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.3 | 44.6 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.3 | 4.2 | GO:0097470 | ribbon synapse(GO:0097470) |
0.3 | 24.9 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.3 | 2.1 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.3 | 2.7 | GO:0033263 | CORVET complex(GO:0033263) |
0.3 | 14.5 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.3 | 2.9 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.3 | 24.0 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.3 | 2.0 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.2 | 3.7 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.2 | 5.4 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.2 | 5.4 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.2 | 2.0 | GO:0016272 | prefoldin complex(GO:0016272) |
0.2 | 1.7 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
0.2 | 1.2 | GO:0000125 | PCAF complex(GO:0000125) |
0.2 | 2.4 | GO:0005884 | actin filament(GO:0005884) |
0.2 | 2.5 | GO:0000322 | storage vacuole(GO:0000322) |
0.2 | 2.7 | GO:0030870 | Mre11 complex(GO:0030870) |
0.2 | 1.6 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.2 | 2.6 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.2 | 4.7 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.2 | 5.6 | GO:0042627 | chylomicron(GO:0042627) |
0.2 | 4.5 | GO:0043679 | axon terminus(GO:0043679) |
0.2 | 1.9 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.2 | 0.9 | GO:0035061 | interchromatin granule(GO:0035061) |
0.2 | 0.7 | GO:0055087 | Ski complex(GO:0055087) |
0.2 | 1.2 | GO:0097427 | microtubule bundle(GO:0097427) |
0.2 | 1.7 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.2 | 1.7 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.2 | 86.6 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.2 | 72.4 | GO:0034774 | secretory granule lumen(GO:0034774) |
0.2 | 1.0 | GO:0030008 | TRAPP complex(GO:0030008) |
0.2 | 2.1 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.2 | 1.9 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.2 | 3.8 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.2 | 1.4 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 1.6 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.1 | 5.8 | GO:0032590 | dendrite membrane(GO:0032590) |
0.1 | 3.2 | GO:0000785 | chromatin(GO:0000785) |
0.1 | 0.5 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.1 | 1.1 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 2.4 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.1 | 11.1 | GO:0043198 | dendritic shaft(GO:0043198) |
0.1 | 1.3 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.1 | 10.0 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 16.8 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 15.6 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 13.1 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 0.9 | GO:0097452 | GAIT complex(GO:0097452) |
0.1 | 1.0 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.1 | 1.1 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 4.1 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 0.4 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.1 | 2.4 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 2.1 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 1.3 | GO:0072487 | MSL complex(GO:0072487) |
0.1 | 2.0 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.1 | 7.9 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 2.2 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.1 | 7.1 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 3.7 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 20.2 | GO:0001650 | fibrillar center(GO:0001650) |
0.1 | 6.8 | GO:0030427 | site of polarized growth(GO:0030427) |
0.1 | 8.9 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.1 | 0.5 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.1 | 33.6 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.1 | 2.9 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.1 | 7.7 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.1 | 1.0 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 0.9 | GO:0038201 | TOR complex(GO:0038201) |
0.1 | 103.9 | GO:0000139 | Golgi membrane(GO:0000139) |
0.1 | 19.4 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 1.0 | GO:0005955 | calcineurin complex(GO:0005955) |
0.1 | 23.6 | GO:0030496 | midbody(GO:0030496) |
0.1 | 0.7 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.1 | 1.2 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 24.7 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.1 | 2.7 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 6.4 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.1 | 4.2 | GO:0032155 | cell division site(GO:0032153) cleavage furrow(GO:0032154) cell division site part(GO:0032155) cell surface furrow(GO:0097610) |
0.1 | 2.7 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.1 | 2.1 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.1 | 1.9 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 4.3 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 13.7 | GO:0031252 | cell leading edge(GO:0031252) |
0.1 | 2.0 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
0.1 | 0.7 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.1 | 1.9 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 0.5 | GO:1990246 | uniplex complex(GO:1990246) |
0.1 | 0.6 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.1 | 5.4 | GO:0005902 | microvillus(GO:0005902) |
0.1 | 0.8 | GO:0070187 | telosome(GO:0070187) |
0.1 | 3.5 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.1 | 1.3 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 10.5 | GO:0016605 | PML body(GO:0016605) |
0.1 | 7.2 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 0.3 | GO:0035748 | Scrib-APC-beta-catenin complex(GO:0034750) myelin sheath abaxonal region(GO:0035748) |
0.1 | 3.1 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 4.7 | GO:0012505 | endomembrane system(GO:0012505) |
0.1 | 20.2 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.1 | 21.1 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 1.8 | GO:0098791 | Golgi subcompartment(GO:0098791) |
0.1 | 0.4 | GO:0032044 | DSIF complex(GO:0032044) |
0.1 | 0.7 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 11.3 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 1.0 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 1.0 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 0.3 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 0.6 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
0.1 | 0.5 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.1 | 0.7 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 12.2 | GO:0031965 | nuclear membrane(GO:0031965) |
0.1 | 1.8 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.1 | 1.6 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 6.0 | GO:0036064 | ciliary basal body(GO:0036064) |
0.0 | 0.3 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) ERCC4-ERCC1 complex(GO:0070522) |
0.0 | 0.2 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.0 | 22.2 | GO:0005925 | focal adhesion(GO:0005925) |
0.0 | 1.1 | GO:0031105 | septin complex(GO:0031105) |
0.0 | 1.8 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 0.1 | GO:0097422 | tubular endosome(GO:0097422) |
0.0 | 0.2 | GO:0098793 | presynapse(GO:0098793) |
0.0 | 0.2 | GO:0005687 | U4 snRNP(GO:0005687) |
0.0 | 1.8 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.8 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 1.2 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.0 | 4.3 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.0 | 0.2 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
0.0 | 0.1 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.0 | 6.7 | GO:0005741 | mitochondrial outer membrane(GO:0005741) organelle outer membrane(GO:0031968) |
0.0 | 0.4 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.0 | 7.9 | GO:0016607 | nuclear speck(GO:0016607) |
0.0 | 7.3 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 1.3 | GO:0030133 | transport vesicle(GO:0030133) |
0.0 | 174.2 | GO:0005829 | cytosol(GO:0005829) |
0.0 | 1.1 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.0 | 0.6 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.0 | 0.4 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.0 | 0.8 | GO:0005770 | late endosome(GO:0005770) |
0.0 | 0.0 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.0 | 2.7 | GO:0044432 | endoplasmic reticulum part(GO:0044432) |
0.0 | 0.3 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.2 | GO:0005657 | replication fork(GO:0005657) |
0.0 | 0.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 1.6 | GO:0044454 | nuclear chromosome part(GO:0044454) |
0.0 | 0.2 | GO:0002178 | palmitoyltransferase complex(GO:0002178) serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.0 | 0.2 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.7 | 20.1 | GO:0005174 | CD40 receptor binding(GO:0005174) |
6.3 | 12.6 | GO:0004917 | interleukin-7 receptor activity(GO:0004917) |
5.9 | 47.2 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
5.9 | 29.3 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
4.8 | 76.2 | GO:0042608 | T cell receptor binding(GO:0042608) |
4.5 | 13.5 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
4.0 | 47.6 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
3.6 | 29.0 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
3.5 | 45.5 | GO:0051525 | NFAT protein binding(GO:0051525) |
3.4 | 10.3 | GO:0031859 | platelet activating factor receptor binding(GO:0031859) |
3.2 | 28.7 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
2.9 | 17.3 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
2.7 | 10.9 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
2.6 | 17.9 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
2.5 | 98.0 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
2.3 | 28.1 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
2.3 | 7.0 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
2.3 | 55.7 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
2.3 | 6.9 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
2.2 | 24.7 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
2.2 | 20.1 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
2.2 | 6.5 | GO:0016517 | interleukin-12 receptor activity(GO:0016517) |
2.1 | 12.5 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
2.0 | 44.4 | GO:0005522 | profilin binding(GO:0005522) |
1.9 | 5.6 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
1.8 | 7.3 | GO:0004979 | beta-endorphin receptor activity(GO:0004979) morphine receptor activity(GO:0038047) |
1.7 | 39.8 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
1.5 | 7.5 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
1.5 | 7.3 | GO:0070051 | fibrinogen binding(GO:0070051) |
1.4 | 8.6 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
1.4 | 4.3 | GO:0001160 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
1.4 | 24.0 | GO:0019957 | C-C chemokine binding(GO:0019957) |
1.4 | 10.8 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
1.3 | 10.7 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
1.3 | 6.6 | GO:0019770 | IgG receptor activity(GO:0019770) |
1.3 | 9.0 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
1.3 | 8.9 | GO:0003920 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
1.2 | 45.5 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
1.2 | 3.7 | GO:0070119 | ciliary neurotrophic factor binding(GO:0070119) |
1.2 | 44.7 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
1.2 | 27.6 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
1.1 | 17.2 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
1.1 | 4.6 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
1.1 | 5.6 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
1.1 | 4.4 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
1.1 | 12.6 | GO:0019864 | IgG binding(GO:0019864) |
1.0 | 77.1 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
1.0 | 10.2 | GO:1990405 | protein antigen binding(GO:1990405) |
1.0 | 3.0 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
1.0 | 18.6 | GO:0030284 | estrogen receptor activity(GO:0030284) |
1.0 | 2.9 | GO:0003881 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity(GO:0003881) |
0.9 | 48.2 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.9 | 3.7 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
0.9 | 18.3 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.9 | 2.7 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
0.9 | 13.4 | GO:0033691 | sialic acid binding(GO:0033691) |
0.9 | 3.5 | GO:0061769 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
0.9 | 19.0 | GO:0051400 | BH domain binding(GO:0051400) |
0.8 | 11.0 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.8 | 3.2 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.8 | 6.4 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.8 | 19.6 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.8 | 3.8 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
0.8 | 14.6 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.8 | 3.1 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.8 | 5.3 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.7 | 21.0 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.7 | 3.5 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.7 | 3.5 | GO:0005457 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
0.7 | 2.7 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.7 | 27.2 | GO:0017166 | vinculin binding(GO:0017166) |
0.7 | 23.1 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.7 | 2.0 | GO:0036440 | citrate (Si)-synthase activity(GO:0004108) citrate synthase activity(GO:0036440) |
0.7 | 2.0 | GO:0050146 | nucleoside phosphotransferase activity(GO:0050146) |
0.7 | 2.0 | GO:0050254 | rhodopsin kinase activity(GO:0050254) |
0.7 | 4.0 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.7 | 7.9 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.6 | 1.9 | GO:0036328 | VEGF-C-activated receptor activity(GO:0036328) |
0.6 | 5.0 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.6 | 4.4 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.6 | 92.0 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.6 | 9.5 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.6 | 22.8 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.6 | 13.3 | GO:0050700 | CARD domain binding(GO:0050700) |
0.5 | 4.9 | GO:0004883 | glucocorticoid receptor activity(GO:0004883) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
0.5 | 8.8 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.5 | 1.6 | GO:0086040 | sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential(GO:0086040) |
0.5 | 5.8 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.5 | 55.0 | GO:1990782 | protein tyrosine kinase binding(GO:1990782) |
0.5 | 1.5 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
0.5 | 2.5 | GO:0023023 | MHC protein complex binding(GO:0023023) |
0.5 | 5.0 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.5 | 2.5 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.5 | 4.9 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.5 | 3.9 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.5 | 4.8 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.5 | 21.6 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.5 | 2.4 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.5 | 238.4 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.5 | 4.2 | GO:0030267 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.5 | 5.1 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.5 | 8.7 | GO:0030957 | Tat protein binding(GO:0030957) |
0.4 | 2.7 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.4 | 0.9 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.4 | 2.2 | GO:0035500 | MH2 domain binding(GO:0035500) |
0.4 | 14.7 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.4 | 4.2 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.4 | 7.0 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.4 | 1.6 | GO:0098808 | mRNA cap binding(GO:0098808) |
0.4 | 4.8 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.4 | 2.0 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
0.4 | 2.0 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.4 | 19.1 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.4 | 10.6 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.4 | 19.7 | GO:0042287 | MHC protein binding(GO:0042287) |
0.4 | 2.9 | GO:0019826 | oxygen sensor activity(GO:0019826) |
0.4 | 12.4 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.4 | 11.3 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.3 | 7.6 | GO:0043274 | phospholipase binding(GO:0043274) |
0.3 | 3.1 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.3 | 13.5 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.3 | 2.0 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
0.3 | 3.0 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.3 | 1.3 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.3 | 3.3 | GO:0050542 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.3 | 2.6 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.3 | 9.4 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.3 | 2.8 | GO:0043426 | MRF binding(GO:0043426) |
0.3 | 2.8 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.3 | 1.8 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.3 | 0.9 | GO:0004379 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
0.3 | 14.7 | GO:0043236 | laminin binding(GO:0043236) |
0.3 | 1.5 | GO:0033265 | choline binding(GO:0033265) |
0.3 | 2.7 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.3 | 5.0 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.3 | 2.7 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.3 | 21.8 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.3 | 2.0 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.3 | 2.0 | GO:0005119 | smoothened binding(GO:0005119) |
0.3 | 5.8 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.3 | 2.2 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.3 | 1.6 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.3 | 4.3 | GO:0045159 | myosin II binding(GO:0045159) |
0.3 | 2.2 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.3 | 1.6 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.3 | 3.5 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.3 | 6.6 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.3 | 0.8 | GO:0015616 | DNA translocase activity(GO:0015616) |
0.3 | 9.0 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.3 | 2.9 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.3 | 9.0 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.3 | 12.0 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.3 | 3.3 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.3 | 1.3 | GO:0008457 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
0.3 | 38.8 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.2 | 6.6 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.2 | 11.1 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.2 | 0.7 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.2 | 1.6 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.2 | 2.8 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.2 | 4.1 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.2 | 2.7 | GO:0034594 | phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity(GO:0034485) phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.2 | 7.3 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.2 | 2.4 | GO:0008607 | cAMP-dependent protein kinase regulator activity(GO:0008603) phosphorylase kinase regulator activity(GO:0008607) |
0.2 | 18.3 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.2 | 7.6 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.2 | 11.6 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.2 | 1.6 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.2 | 3.0 | GO:0015925 | galactosidase activity(GO:0015925) |
0.2 | 1.4 | GO:0047522 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
0.2 | 8.5 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.2 | 4.0 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.2 | 1.1 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
0.2 | 12.9 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.2 | 3.8 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.2 | 0.7 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.2 | 1.7 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.2 | 6.2 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.2 | 8.6 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.2 | 18.3 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.2 | 3.6 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 1.2 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.1 | 1.9 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.1 | 8.0 | GO:0008134 | transcription factor binding(GO:0008134) |
0.1 | 2.1 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.1 | 2.6 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.1 | 11.5 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 5.1 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.8 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 3.4 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 2.1 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.1 | 61.3 | GO:0003924 | GTPase activity(GO:0003924) |
0.1 | 1.4 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 1.0 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.1 | 4.5 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 0.6 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
0.1 | 3.1 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 5.5 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 3.9 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.1 | 1.9 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
0.1 | 4.1 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 0.6 | GO:0098625 | methylselenol reductase activity(GO:0098625) methylseleninic acid reductase activity(GO:0098626) |
0.1 | 4.3 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.1 | 3.6 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.1 | 1.0 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.1 | 3.2 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.1 | 2.2 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 1.9 | GO:0032183 | SUMO binding(GO:0032183) |
0.1 | 2.1 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.1 | 6.7 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.1 | 4.2 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 1.6 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.1 | 4.0 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 5.3 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.1 | 1.7 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 7.9 | GO:0035004 | phosphatidylinositol 3-kinase activity(GO:0035004) |
0.1 | 2.1 | GO:0046961 | hydrogen-exporting ATPase activity(GO:0036442) proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.1 | 1.1 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 4.1 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 2.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.1 | 1.8 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.1 | 0.9 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.1 | 3.6 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 3.6 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.1 | 2.8 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.1 | 1.2 | GO:0035326 | enhancer binding(GO:0035326) |
0.1 | 0.9 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 7.7 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 0.8 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 1.7 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.1 | 9.6 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 1.9 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 18.4 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 0.9 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.1 | 0.6 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.1 | 1.6 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 4.0 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.1 | 11.2 | GO:0004386 | helicase activity(GO:0004386) |
0.1 | 1.0 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 2.4 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 1.4 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 0.5 | GO:0004064 | arylesterase activity(GO:0004064) |
0.1 | 0.8 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.1 | 0.6 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 3.5 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.1 | 19.0 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.1 | 0.9 | GO:0008494 | translation activator activity(GO:0008494) |
0.1 | 0.3 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 8.0 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.1 | 1.7 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 1.0 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 2.5 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 11.3 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.1 | 1.8 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.1 | 3.3 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 0.3 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.0 | 3.8 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.0 | 1.3 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 0.5 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
0.0 | 1.0 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.0 | 0.2 | GO:0030911 | TPR domain binding(GO:0030911) |
0.0 | 1.5 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.0 | 2.1 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.0 | 1.5 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.0 | 1.9 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.0 | 10.7 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.5 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.0 | 1.3 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 1.5 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 4.1 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.0 | 0.7 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.6 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.0 | 0.4 | GO:0034452 | dynactin binding(GO:0034452) |
0.0 | 3.5 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.0 | 4.8 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 0.3 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.2 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.0 | 0.1 | GO:0004337 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
0.0 | 1.4 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.0 | 3.4 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.9 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.3 | GO:0000149 | SNARE binding(GO:0000149) |
0.0 | 0.4 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.0 | 3.4 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.1 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.0 | 0.1 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.0 | 7.6 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 2.7 | GO:0003823 | antigen binding(GO:0003823) |
0.0 | 0.2 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.2 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.0 | 0.1 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.9 | 359.0 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
1.7 | 70.3 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
1.7 | 74.9 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
1.3 | 48.6 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
1.3 | 88.0 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.9 | 51.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.9 | 66.3 | PID BCR 5PATHWAY | BCR signaling pathway |
0.9 | 25.1 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.9 | 45.2 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.9 | 15.6 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.9 | 62.0 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.9 | 31.7 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.8 | 21.5 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.8 | 108.3 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.7 | 79.4 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.7 | 2.9 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.6 | 12.9 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.6 | 59.4 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.6 | 21.0 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.6 | 15.4 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.5 | 2.4 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.5 | 58.8 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.5 | 12.6 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.5 | 10.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.4 | 16.0 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.4 | 19.7 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.4 | 16.0 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.4 | 4.9 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.4 | 63.8 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.4 | 13.5 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.4 | 29.4 | PID AURORA B PATHWAY | Aurora B signaling |
0.4 | 7.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.4 | 16.2 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.4 | 5.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.4 | 14.2 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.3 | 12.0 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.3 | 19.9 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.3 | 2.7 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.3 | 20.8 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.3 | 29.7 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.2 | 8.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.2 | 8.7 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.2 | 10.9 | PID ENDOTHELIN PATHWAY | Endothelins |
0.2 | 10.7 | PID ARF6 PATHWAY | Arf6 signaling events |
0.2 | 5.6 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.2 | 17.4 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.2 | 5.4 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.2 | 4.2 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.2 | 2.0 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.2 | 3.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 6.8 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 0.7 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 1.9 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 8.6 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 1.7 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 1.3 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 2.8 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 0.5 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 2.3 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 1.8 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 5.4 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 1.5 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 3.7 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 2.8 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 2.0 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 1.5 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 12.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 3.5 | PID P53 REGULATION PATHWAY | p53 pathway |
0.0 | 2.0 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 1.0 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 1.1 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 12.0 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.2 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 1.2 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 1.2 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 1.1 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 1.4 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 0.5 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.4 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.0 | 230.5 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
4.9 | 14.7 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
2.4 | 94.2 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
2.2 | 20.2 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
1.9 | 1.9 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
1.6 | 187.1 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
1.5 | 19.8 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
1.3 | 27.8 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
1.3 | 87.3 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
1.1 | 35.3 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
1.1 | 59.5 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
1.1 | 20.2 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
1.0 | 58.8 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.9 | 20.6 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.9 | 5.6 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.9 | 48.2 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.9 | 27.6 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.9 | 19.6 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.8 | 12.6 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.8 | 13.2 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.7 | 10.9 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.7 | 13.8 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.7 | 19.7 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.6 | 11.0 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.6 | 6.9 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.6 | 46.5 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.6 | 0.6 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.6 | 163.2 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.6 | 14.1 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.6 | 6.7 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.5 | 5.3 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.5 | 10.3 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.5 | 2.5 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.5 | 13.8 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.5 | 25.6 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.4 | 21.8 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.4 | 4.4 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.4 | 14.6 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.4 | 13.4 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.4 | 22.1 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.4 | 32.8 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.4 | 3.5 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.4 | 9.0 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.3 | 4.7 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.3 | 8.9 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.3 | 8.9 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.3 | 7.3 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.3 | 3.9 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.3 | 4.9 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.3 | 3.3 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.2 | 5.0 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.2 | 1.4 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.2 | 3.7 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.2 | 35.3 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.2 | 5.6 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.2 | 6.0 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.2 | 9.5 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.2 | 30.0 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.2 | 3.9 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.2 | 17.3 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.2 | 8.3 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.2 | 2.4 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.2 | 0.3 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.2 | 5.3 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.2 | 2.4 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 6.8 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 4.0 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 4.8 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.1 | 5.0 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.1 | 8.7 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 2.3 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.1 | 11.1 | REACTOME MITOTIC G1 G1 S PHASES | Genes involved in Mitotic G1-G1/S phases |
0.1 | 3.8 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 2.0 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 0.6 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 1.5 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.1 | 23.0 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.1 | 2.4 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.1 | 7.5 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 0.4 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 10.1 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 2.1 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.1 | 2.0 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 1.6 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.1 | 2.8 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 0.4 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.0 | 1.6 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.0 | 5.6 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.8 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.0 | 0.4 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.0 | 2.8 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 1.7 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 1.0 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 1.8 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 0.9 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.0 | 1.5 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 1.1 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.0 | 2.4 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.0 | 2.1 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.0 | 1.5 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 2.5 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 1.8 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 1.5 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.0 | 0.6 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 1.6 | REACTOME TRANSLATION | Genes involved in Translation |
0.0 | 1.1 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.0 | 1.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 2.3 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 1.1 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 1.0 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.0 | 0.4 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 1.2 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.3 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.0 | 0.4 | REACTOME METABOLISM OF NUCLEOTIDES | Genes involved in Metabolism of nucleotides |
0.0 | 0.7 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 0.3 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.5 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.6 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.2 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 0.2 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |